MERCK KGAA NAM.SP.ADR (F:MRKC) — Market Cap & Net Worth
Market Cap & Net Worth: MERCK KGAA NAM.SP.ADR (MRKC)
MERCK KGAA NAM.SP.ADR (F:MRKC) has a market capitalization of $17.07 Billion (€14.60 Billion) as of August 1, 2026. Listed on the F stock exchange, this Germany-based company holds position #1457 globally and #326 in its home market, demonstrating a -1.74% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MERCK KGAA NAM.SP.ADR's stock price €22.60 by its total outstanding shares 646211255 (646.21 Million). See capital reinvestment ratio of MERCK KGAA NAM.SP.ADR to understand how much of operating cash flow is reinvested back into capital assets.
MERCK KGAA NAM.SP.ADR Market Cap History: 2020 to 2026
MERCK KGAA NAM.SP.ADR's market capitalization history from 2020 to 2026. Data shows change from $19.90 Billion to $21.46 Billion (-0.40% CAGR).
MERCK KGAA NAM.SP.ADR Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MERCK KGAA NAM.SP.ADR's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.86x
MERCK KGAA NAM.SP.ADR's market cap is 0.86 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.95x
MERCK KGAA NAM.SP.ADR's market cap is 6.95 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $19.90 Billion | $17.53 Billion | $1.99 Billion | 1.13x | 10.01x |
| 2021 | $33.46 Billion | $19.69 Billion | $3.06 Billion | 1.70x | 10.95x |
| 2022 | $26.51 Billion | $22.23 Billion | $3.33 Billion | 1.19x | 7.97x |
| 2023 | $20.96 Billion | $20.99 Billion | $2.82 Billion | 1.00x | 7.42x |
| 2024 | $20.70 Billion | $21.16 Billion | $2.78 Billion | 0.98x | 7.45x |
| 2025 | $18.13 Billion | $21.10 Billion | $2.61 Billion | 0.86x | 6.95x |
Competitor Companies of MRKC by Market Capitalization
Companies near MERCK KGAA NAM.SP.ADR in the global market cap rankings as of August 1, 2026.
Key companies related to MERCK KGAA NAM.SP.ADR by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #503 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #528 globally with a market cap of $50.48 Billion USD ( CN¥344.98 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #550 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #503 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #528 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.48 Billion | CN¥54.08 |
| #550 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.60 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €15.50 |
MERCK KGAA NAM.SP.ADR Historical Marketcap From 2020 to 2026
Between 2020 and today, MERCK KGAA NAM.SP.ADR's market cap moved from $19.90 Billion to $ 21.46 Billion, with a yearly change of -0.40%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €21.46 Billion | +18.33% |
| 2025 | €18.13 Billion | -12.41% |
| 2024 | €20.70 Billion | -1.26% |
| 2023 | €20.96 Billion | -20.92% |
| 2022 | €26.51 Billion | -20.78% |
| 2021 | €33.46 Billion | +68.18% |
| 2020 | €19.90 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of MERCK KGAA NAM.SP.ADR was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.07 Billion USD |
| MoneyControl | $17.07 Billion USD |
| MarketWatch | $17.07 Billion USD |
| marketcap.company | $17.07 Billion USD |
| Reuters | $17.07 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About MERCK KGAA NAM.SP.ADR
Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more